Loading...
•
Dec 31, 2021
ICU Medical Q4 2021 Earnings Report
Announced fourth quarter 2021 results
Key Takeaways
ICU Medical reported Q4 2021 revenue of $340.5 million, compared to $320.5 million in the same period last year. GAAP net income for the fourth quarter of 2021 was $19.9 million, or $0.91 per diluted share, as compared to GAAP net income of $26.1 million, or $1.21 per diluted share, for the fourth quarter of 2020.
Fourth quarter revenue was $340.5 million, compared to $320.5 million in the same period last year.
GAAP gross profit for the fourth quarter of 2021 was $127.5 million, as compared to $119.9 million in the same period last year.
GAAP net income for the fourth quarter of 2021 was $19.9 million, or $0.91 per diluted share, as compared to GAAP net income of $26.1 million, or $1.21 per diluted share, for the fourth quarter of 2020.
Adjusted diluted earnings per share for the fourth quarter of 2021 was $1.82 as compared to $1.77 for the fourth quarter of 2020.
Revenue by Segment
Forward Guidance
For the Fiscal Year 2022, the Company expects adjusted EBITDA to be in the range of $450 million to $500 million, and adjusted diluted EPS to be in the range of $9.00 to $10.50.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...